We are analyzing https://link.springer.com/article/10.1186/s12943-017-0600-4.

Title:
Intra-tumor heterogeneity from a cancer stem cell perspective | Molecular Cancer
Description:
Tumor heterogeneity represents an ongoing challenge in the field of cancer therapy. Heterogeneity is evident between cancers from different patients (inter-tumor heterogeneity) and within a single tumor (intra-tumor heterogeneity). The latter includes phenotypic diversity such as cell surface markers, (epi)genetic abnormality, growth rate, apoptosis and other hallmarks of cancer that eventually drive disease progression and treatment failure. Cancer stem cells (CSCs) have been put forward to be one of the determining factors that contribute to intra-tumor heterogeneity. However, recent findings have shown that the stem-like state in a given tumor cell is a plastic quality. A corollary to this view is that stemness traits can be acquired via (epi)genetic modification and/or interaction with the tumor microenvironment (TME). Here we discuss factors contributing to this CSC heterogeneity and the potential implications for cancer therapy.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Health & Fitness
Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,603,724 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

cancer, cells, cell, tumor, pubmed, stem, article, google, scholar, cas, cscs, csc, heterogeneity, microenvironment, epigenetic, nature, growth, model, central, breast, therapy, genetic, httpwwwncbinlmnihgovpubmed, matrix, expression, intratumor, mutations, selfrenewal, nat, shown, stemness, tumour, plasticity, ecm, instance, features, role, factors, induce, medema, state, clonal, clones, normal, mutation, alterations, internet, population, endothelial, differentiated,

Topics {✒️}

cmd=retrieve&db=pubmed&dopt=citation&list_uids=12714970 /nbt/journal/v32/n1/full/nbt /nature/journal/v367/n6464/abs/367645a0 org/en/content/articlehtml/2015/ib/c5ib00040h artid=3427400&tool=pmcentrez&rendertype=abstract artid=4128640&tool=pmcentrez&rendertype=abstract artid=3060261&tool=pmcentrez&rendertype=abstract artid=1728259&tool=pmcentrez&rendertype=abstract artid=4539660&tool=pmcentrez&rendertype=abstract artid=2386807&tool=pmcentrez&rendertype=abstract meis1-mn1-hoxa gene clusters human colon-cancer-initiating cells /ncomms/2016/160118/ncomms10305/full/ncomms10305 /ncomms/2015/150402/ncomms7411/full/ncomms7411 activate stat3/nf-κb jan paul medema transforming growth factor-beta vegf–nrp1 loop regulate integrin-linked kinase overexpression article download pdf academic medical center cell-ecm cross-talk change tumor intra-heterogeneity change intra-tumor heterogeneity oxygen-dependent h3k27me3 demethylases tumour micro-environment heterogeneity mutated stem cells ilk/pi3k/akt pathway integrin-linked kinase ilk complex fine-tuning modification gov/pmc/articles/pmc1891215/ reduced intra-tumor heterogeneity related subjects ras-raf axis underlie article prasetyanti oncogenic kras-induced leukemogeneis develop csc-specific therapies install intra-tumor heterogeneity gravitation program zonmw /article/s0092867406013481/fulltext distinct csc-driven clones stem cell biology epithelial-mesenchymal transition differential matrix stiffness hematopoietic stem cells cancer stem cell acute myeloid leukemia cell stem cell tumour-initiating cells privacy choices/manage cookies

Questions {❓}

Breast tumor heterogeneity: cancer stem cells or clonal evolution?
How then does the microenvironment stimulate stem cell expansion?
Inflammation and cancer: Back to Virchow?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Intra-tumor heterogeneity from a cancer stem cell perspective
         description:Tumor heterogeneity represents an ongoing challenge in the field of cancer therapy. Heterogeneity is evident between cancers from different patients (inter-tumor heterogeneity) and within a single tumor (intra-tumor heterogeneity). The latter includes phenotypic diversity such as cell surface markers, (epi)genetic abnormality, growth rate, apoptosis and other hallmarks of cancer that eventually drive disease progression and treatment failure. Cancer stem cells (CSCs) have been put forward to be one of the determining factors that contribute to intra-tumor heterogeneity. However, recent findings have shown that the stem-like state in a given tumor cell is a plastic quality. A corollary to this view is that stemness traits can be acquired via (epi)genetic modification and/or interaction with the tumor microenvironment (TME). Here we discuss factors contributing to this CSC heterogeneity and the potential implications for cancer therapy.
         datePublished:2017-02-16T00:00:00Z
         dateModified:2017-02-16T00:00:00Z
         pageStart:1
         pageEnd:9
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12943-017-0600-4
         keywords:
            Tumor heterogeneity
            Cancer stem cell
            Stemness
            Tumor microenvironment
            Cancer Research
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0600-4/MediaObjects/12943_2017_600_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0600-4/MediaObjects/12943_2017_600_Fig2_HTML.gif
         isPartOf:
            name:Molecular Cancer
            issn:
               1476-4598
            volumeNumber:16
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Pramudita R. Prasetyanti
               affiliation:
                     name:University of Amsterdam
                     address:
                        name:Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM), Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
                     name:Cancer Center Amsterdam and Cancer Genomics Center
                     address:
                        name:Cancer Center Amsterdam and Cancer Genomics Center, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jan Paul Medema
               url:http://orcid.org/0000-0003-3045-2924
               affiliation:
                     name:University of Amsterdam
                     address:
                        name:Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM), Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
                     name:Cancer Center Amsterdam and Cancer Genomics Center
                     address:
                        name:Cancer Center Amsterdam and Cancer Genomics Center, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
                     name:Academic Medical Center
                     address:
                        name:Academic Medical Center, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Intra-tumor heterogeneity from a cancer stem cell perspective
      description:Tumor heterogeneity represents an ongoing challenge in the field of cancer therapy. Heterogeneity is evident between cancers from different patients (inter-tumor heterogeneity) and within a single tumor (intra-tumor heterogeneity). The latter includes phenotypic diversity such as cell surface markers, (epi)genetic abnormality, growth rate, apoptosis and other hallmarks of cancer that eventually drive disease progression and treatment failure. Cancer stem cells (CSCs) have been put forward to be one of the determining factors that contribute to intra-tumor heterogeneity. However, recent findings have shown that the stem-like state in a given tumor cell is a plastic quality. A corollary to this view is that stemness traits can be acquired via (epi)genetic modification and/or interaction with the tumor microenvironment (TME). Here we discuss factors contributing to this CSC heterogeneity and the potential implications for cancer therapy.
      datePublished:2017-02-16T00:00:00Z
      dateModified:2017-02-16T00:00:00Z
      pageStart:1
      pageEnd:9
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12943-017-0600-4
      keywords:
         Tumor heterogeneity
         Cancer stem cell
         Stemness
         Tumor microenvironment
         Cancer Research
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0600-4/MediaObjects/12943_2017_600_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12943-017-0600-4/MediaObjects/12943_2017_600_Fig2_HTML.gif
      isPartOf:
         name:Molecular Cancer
         issn:
            1476-4598
         volumeNumber:16
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Pramudita R. Prasetyanti
            affiliation:
                  name:University of Amsterdam
                  address:
                     name:Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM), Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
                  name:Cancer Center Amsterdam and Cancer Genomics Center
                  address:
                     name:Cancer Center Amsterdam and Cancer Genomics Center, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jan Paul Medema
            url:http://orcid.org/0000-0003-3045-2924
            affiliation:
                  name:University of Amsterdam
                  address:
                     name:Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM), Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
                  name:Cancer Center Amsterdam and Cancer Genomics Center
                  address:
                     name:Cancer Center Amsterdam and Cancer Genomics Center, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
                  name:Academic Medical Center
                  address:
                     name:Academic Medical Center, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Molecular Cancer
      issn:
         1476-4598
      volumeNumber:16
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Amsterdam
      address:
         name:Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM), Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands
         type:PostalAddress
      name:Cancer Center Amsterdam and Cancer Genomics Center
      address:
         name:Cancer Center Amsterdam and Cancer Genomics Center, Amsterdam, The Netherlands
         type:PostalAddress
      name:University of Amsterdam
      address:
         name:Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM), Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands
         type:PostalAddress
      name:Cancer Center Amsterdam and Cancer Genomics Center
      address:
         name:Cancer Center Amsterdam and Cancer Genomics Center, Amsterdam, The Netherlands
         type:PostalAddress
      name:Academic Medical Center
      address:
         name:Academic Medical Center, Amsterdam, The Netherlands
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Pramudita R. Prasetyanti
      affiliation:
            name:University of Amsterdam
            address:
               name:Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM), Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
            name:Cancer Center Amsterdam and Cancer Genomics Center
            address:
               name:Cancer Center Amsterdam and Cancer Genomics Center, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Jan Paul Medema
      url:http://orcid.org/0000-0003-3045-2924
      affiliation:
            name:University of Amsterdam
            address:
               name:Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM), Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
            name:Cancer Center Amsterdam and Cancer Genomics Center
            address:
               name:Cancer Center Amsterdam and Cancer Genomics Center, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
            name:Academic Medical Center
            address:
               name:Academic Medical Center, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM), Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands
      name:Cancer Center Amsterdam and Cancer Genomics Center, Amsterdam, The Netherlands
      name:Laboratory for Experimental Oncology and Radiobiology (LEXOR), Center for Experimental Molecular Medicine (CEMM), Academic Medical Center (AMC), University of Amsterdam, Amsterdam, The Netherlands
      name:Cancer Center Amsterdam and Cancer Genomics Center, Amsterdam, The Netherlands
      name:Academic Medical Center, Amsterdam, The Netherlands

External Links {🔗}(256)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.96s.

LINK . SPRINGER . COM {}